189 related articles for article (PubMed ID: 22231819)
1. Animal models of nicotine withdrawal: intracranial self-stimulation and somatic signs of withdrawal.
Bauzo RM; Bruijnzeel AW
Methods Mol Biol; 2012; 829():257-68. PubMed ID: 22231819
[TBL] [Abstract][Full Text] [Related]
2. Recent Updates in Animal Models of Nicotine Withdrawal: Intracranial Self-Stimulation and Somatic Signs.
Levin B; Wilks I; Tan S; Behnood-Rod A; Bruijnzeel A
Methods Mol Biol; 2019; 2011():253-265. PubMed ID: 31273703
[TBL] [Abstract][Full Text] [Related]
3. Preadolescent tobacco smoke exposure leads to acute nicotine dependence but does not affect the rewarding effects of nicotine or nicotine withdrawal in adulthood in rats.
Yamada H; Bishnoi M; Keijzers KF; van Tuijl IA; Small E; Shah HP; Bauzo RM; Kobeissy FH; Sabarinath SN; Derendorf H; Bruijnzeel AW
Pharmacol Biochem Behav; 2010 Jun; 95(4):401-9. PubMed ID: 20211642
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats.
Bruijnzeel AW; Zislis G; Wilson C; Gold MS
Neuropsychopharmacology; 2007 Apr; 32(4):955-63. PubMed ID: 16943772
[TBL] [Abstract][Full Text] [Related]
5. Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review.
Hughes JR
Nicotine Tob Res; 2007 Mar; 9(3):329-39. PubMed ID: 17365765
[TBL] [Abstract][Full Text] [Related]
6. Modeling nicotine addiction in rats.
Caille S; Clemens K; Stinus L; Cador M
Methods Mol Biol; 2012; 829():243-56. PubMed ID: 22231818
[TBL] [Abstract][Full Text] [Related]
7. Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
Jonkman S; Markou A
Neurosci Lett; 2006 May; 400(1-2):140-5. PubMed ID: 16563623
[TBL] [Abstract][Full Text] [Related]
8. Effects of oxytocin on nicotine withdrawal in rats.
Manbeck KE; Shelley D; Schmidt CE; Harris AC
Pharmacol Biochem Behav; 2014 Jan; 116():84-9. PubMed ID: 24239789
[TBL] [Abstract][Full Text] [Related]
9. Methods in tobacco abuse: proteomic changes following second-hand smoke exposure.
Guingab-Cagmat J; Bauzo RM; Bruijnzeel AW; Wang KK; Gold MS; Kobeissy FH
Methods Mol Biol; 2012; 829():329-48. PubMed ID: 22231825
[TBL] [Abstract][Full Text] [Related]
10. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
11. A critical role for the melanocortin 4 receptor in stress-induced relapse to nicotine seeking in rats.
Qi X; Yamada H; Corrie LW; Ji Y; Bauzo RM; Alexander JC; Bruijnzeel AW
Addict Biol; 2015 Mar; 20(2):324-35. PubMed ID: 24612112
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
Ohmura Y; Jutkiewicz EM; Zhang A; Domino EF
Pharmacol Biochem Behav; 2011 Oct; 99(4):552-6. PubMed ID: 21624384
[TBL] [Abstract][Full Text] [Related]
13. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
Cryan JF; Bruijnzeel AW; Skjei KL; Markou A
Psychopharmacology (Berl); 2003 Jul; 168(3):347-58. PubMed ID: 12698231
[TBL] [Abstract][Full Text] [Related]
14. Dramatic decreases in brain reward function during nicotine withdrawal.
Epping-Jordan MP; Watkins SS; Koob GF; Markou A
Nature; 1998 May; 393(6680):76-9. PubMed ID: 9590692
[TBL] [Abstract][Full Text] [Related]
15. Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
Paterson NE; Balfour DJ; Markou A
Nicotine Tob Res; 2008 Jun; 10(6):995-1008. PubMed ID: 18584463
[TBL] [Abstract][Full Text] [Related]
16. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
Guillem K; Vouillac C; Koob GF; Cador M; Stinus L
Biol Psychiatry; 2008 Jan; 63(2):158-63. PubMed ID: 17643399
[TBL] [Abstract][Full Text] [Related]
17. The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat.
Markou A; Paterson NE
Nicotine Tob Res; 2001 Nov; 3(4):361-73. PubMed ID: 11694204
[TBL] [Abstract][Full Text] [Related]
18. Diminished nicotine withdrawal in adolescent rats: implications for vulnerability to addiction.
O'Dell LE; Bruijnzeel AW; Smith RT; Parsons LH; Merves ML; Goldberger BA; Richardson HN; Koob GF; Markou A
Psychopharmacology (Berl); 2006 Jul; 186(4):612-9. PubMed ID: 16598454
[TBL] [Abstract][Full Text] [Related]
19. Extended access to nicotine self-administration leads to dependence: Circadian measures, withdrawal measures, and extinction behavior in rats.
O'Dell LE; Chen SA; Smith RT; Specio SE; Balster RL; Paterson NE; Markou A; Zorrilla EP; Koob GF
J Pharmacol Exp Ther; 2007 Jan; 320(1):180-93. PubMed ID: 17050784
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice.
Mattioli L; Perfumi M
J Psychopharmacol; 2011 Mar; 25(3):402-10. PubMed ID: 19939867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
